Nipro newsletter April 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

DDL 2026
Merxin March 2026
Terumo 05/01
Nipro April 2026
Volume 14 issue 3

SMIs and Soft Mist Nasal Sprays – A Key Defence in the Fight Against the Next Pandemic?

The COVID-19 outbreak has provided a number of lessons for the pharmaceutical industry to consider for future pandemics. Wilbur de Kruijf at Recipharm argues that on...
Continue Reading →
Volume 14 issue 3

Choosing and Developing User-friendly Osmotic Laxatives for a More Patient-centric Portfolio

At least 1 in 10 people worldwide suffer from constipation at some point in their lives.1,2 It affects people of all ages and has many causes. The symptoms of consti...
Continue Reading →
Volume 14 issue 3

Patient-Centric Clinical Trials: Turning Opportunities into Standard Procedures

Over the past year, the industry has heard often and at length, about patient-focused decentralised trials (DCTs), as vendors and some early adopters report their ea...
Continue Reading →
Volume 14 issue 3

Paving the Way to a more Sustainable Future

More Economy and Ecology in Logistics by Small and Thin Multilingual IFU Booklets Sustainability is considered a priority across the entire pharmaceutical packagi...
Continue Reading →
Volume 14 issue 3

Supply Chain Disruptions Bring Short Notice Changes to Ingredients – But Can Your labelling and Artwork Management System Cope?

Supply chain and procurement industry figures have called this the ‘era of the shortage’, with widespread disruption to supply chains, raw materials and ingredient a...
Continue Reading →
Biopharma group march 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025